Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
The Clinical and Economic Benefits Associated WithNovel Multi-Cancer Early Detection Tests:Conference Highlights from the 2022 ISPOR AnnualMeeting
Nima Nabavizadeh
Knight Cancer Translational Oncology Program
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Clinical and Economic Benefits Associated WithNovel Multi-Cancer Early Detection Tests:Conference Highlights from the 2022 ISPOR AnnualMeeting'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Early Detection of Cancer
60%
Economics
49%
Neoplasms
20%
Cell-Free Nucleic Acids
16%
Medical Overuse
15%
Second Primary Neoplasms
14%
Uterine Cervical Neoplasms
11%
Cost-Benefit Analysis
11%
Colorectal Neoplasms
10%
Cause of Death
10%
Breast Neoplasms
8%
Costs and Cost Analysis
7%
Mortality
6%
Population
4%
Therapeutics
2%
Social Sciences
Clinical Benefit
100%
cancer
58%
economics
27%
death rate
10%
costs
10%
cause of death
10%
research and development
8%
clinician
7%
death
6%